SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,508 | -97.5% | 2,514 | -94.5% | 0.00% | – |
| Q2 2023 | $59,785 | -94.5% | 45,988 | -92.5% | 0.00% | -100.0% |
| Q1 2023 | $1,081,332 | +1.4% | 614,393 | +80.9% | 0.00% | 0.0% |
| Q4 2022 | $1,066,265 | -56.2% | 339,575 | -31.7% | 0.00% | 0.0% |
| Q3 2022 | $2,437,000 | +43.4% | 497,338 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $1,699,000 | +132.7% | 410,283 | +226.7% | 0.00% | – |
| Q1 2022 | $730,000 | -73.3% | 125,565 | -65.5% | 0.00% | -100.0% |
| Q4 2021 | $2,731,000 | +31.4% | 364,070 | +57.8% | 0.00% | 0.0% |
| Q3 2021 | $2,079,000 | -61.2% | 230,713 | -48.5% | 0.00% | -66.7% |
| Q2 2021 | $5,365,000 | -1.8% | 448,152 | +2.7% | 0.00% | -25.0% |
| Q1 2021 | $5,466,000 | -25.7% | 436,274 | -7.4% | 0.00% | 0.0% |
| Q4 2020 | $7,355,000 | +136.4% | 471,297 | +43.1% | 0.00% | +100.0% |
| Q3 2020 | $3,111,000 | -25.5% | 329,272 | -29.4% | 0.00% | -33.3% |
| Q2 2020 | $4,178,000 | +42.6% | 466,345 | +1.5% | 0.00% | +50.0% |
| Q1 2020 | $2,929,000 | -12.0% | 459,679 | +15.6% | 0.00% | 0.0% |
| Q4 2019 | $3,328,000 | -9.8% | 397,498 | -2.5% | 0.00% | -33.3% |
| Q3 2019 | $3,689,000 | +12.7% | 407,526 | +34.1% | 0.00% | 0.0% |
| Q2 2019 | $3,272,000 | +38.1% | 303,793 | +22.4% | 0.00% | 0.0% |
| Q1 2019 | $2,369,000 | -65.8% | 248,229 | -58.9% | 0.00% | -57.1% |
| Q4 2018 | $6,927,000 | +54.6% | 603,404 | +128.3% | 0.01% | +40.0% |
| Q3 2018 | $4,480,000 | +0.9% | 264,267 | -15.5% | 0.01% | +25.0% |
| Q2 2018 | $4,441,000 | -3.2% | 312,800 | +29.6% | 0.00% | 0.0% |
| Q1 2018 | $4,586,000 | 0.0% | 241,358 | -13.7% | 0.00% | +33.3% |
| Q4 2017 | $4,586,000 | +130.7% | 279,697 | +111.0% | 0.00% | +50.0% |
| Q3 2017 | $1,988,000 | +484.7% | 132,536 | +242.6% | 0.00% | – |
| Q2 2017 | $340,000 | +319.8% | 38,684 | +151.7% | 0.00% | – |
| Q1 2017 | $81,000 | -47.4% | 15,367 | -69.7% | 0.00% | – |
| Q4 2016 | $154,000 | +38.7% | 50,667 | +112.5% | 0.00% | – |
| Q3 2016 | $111,000 | +50.0% | 23,843 | +83.2% | 0.00% | – |
| Q2 2016 | $74,000 | -80.8% | 13,013 | -79.7% | 0.00% | – |
| Q1 2016 | $386,000 | +93.0% | 63,964 | +190.9% | 0.00% | – |
| Q4 2015 | $200,000 | -59.6% | 21,986 | -75.0% | 0.00% | – |
| Q3 2015 | $495,000 | +75.5% | 87,884 | +246.2% | 0.00% | – |
| Q2 2015 | $282,000 | -35.8% | 25,386 | -9.3% | 0.00% | – |
| Q1 2015 | $439,000 | -31.2% | 27,989 | -33.1% | 0.00% | -100.0% |
| Q4 2014 | $638,000 | +217.4% | 41,868 | +124.5% | 0.00% | – |
| Q3 2014 | $201,000 | +4.7% | 18,648 | +47.9% | 0.00% | – |
| Q2 2014 | $192,000 | -42.5% | 12,606 | -31.8% | 0.00% | – |
| Q1 2014 | $334,000 | -35.3% | 18,490 | -50.1% | 0.00% | – |
| Q4 2013 | $516,000 | +230.8% | 37,081 | +148.4% | 0.00% | – |
| Q3 2013 | $156,000 | +387.5% | 14,925 | +269.0% | 0.00% | – |
| Q2 2013 | $32,000 | – | 4,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |